Effect of rosuvastatin 5-20mg on triglycerides and other lipid parameters in Japanese patients with hypertriglyceridemia.
Atherosclerosis
; 194(2): 505-11, 2007 Oct.
Article
en En
| MEDLINE
| ID: mdl-17223112
ABSTRACT
To evaluate the potential dose effect of rosuvastatin on triglyceride (TG) levels in Japanese hypertriglyceridemic patients, we randomized 154 patients with TG levels of >or=200 and <800 mg/dL to 8 weeks of treatment with rosuvastatin 5, 10 or 20mg once daily; bezafibrate 200mg twice daily; or placebo. Compared with placebo, TG was reduced by 30.1% with rosuvastatin 5mg, 30.1% with 10mg and 32.3% with 20mg (all p
Buscar en Google
Base de datos:
MEDLINE
Asunto principal:
Pirimidinas
/
Sulfonamidas
/
Triglicéridos
/
Bezafibrato
/
Hipertrigliceridemia
/
Inhibidores de Hidroximetilglutaril-CoA Reductasas
/
Fluorobencenos
Tipo de estudio:
Clinical_trials
País/Región como asunto:
Asia
Idioma:
En
Revista:
Atherosclerosis
Año:
2007
Tipo del documento:
Article